Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
AmideBio uses in-silico design and proprietary peptide synthesis to develop preclinical peptide drug candidates for metabolic disease. It also offers custom peptide synthesis services and a catalog of high-purity peptides for customers.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
AMPEL BioSolutions develops RNA-based precision medicine products using its AMPEL Genomic Platform (AGP), which combines RNA analytics and predictive AI to evaluate disease status, identify cellular functions and pathways, and predict disease flares and drug targets from blood and biopsy tests. Its clinical products, such as LuGENE, DermaGENE, and WellGENE, support genomic diagnostics for patient disease management.
0 investors
0 investors
Amphix Bio develops peptide therapeutics based on a supramolecular chemistry platform that forms nanostructure scaffolds to activate regenerative signaling in cells and tissues. Its pipeline targets neurological injuries, neuro-inflammatory diseases, and musculoskeletal disorders.
0 investors
0 investors
0 investors
0 investors
Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump with inflow and outflow catheters that uses proprietary hemodynamic technology to enlarge veins before arteriovenous fistula (AVF) creation. The device is intended to increase patient eligibility for AVF surgery and improve vascular access outcomes for hemodialysis patients.
0 investors
0 investors
0 investors
0 investors
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
0 investors
0 investors
Ananda Scientific develops investigational CBD-based drugs delivered in soft gelatin capsules, with its Nantheia A1002N5S product formulated for rapid gastrointestinal absorption. The company is running FDA-approved clinical trials targeting PTSD, Social Anxiety Disorder, and radiculopathic pain, focusing on treatments for neuropsychiatric disorders.
0 investors
0 investors
0 investors